{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:19:14Z","timestamp":1787818754385,"version":"build-2784847793"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12028-018-0627-4","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T10:28:07Z","timestamp":1539685687000},"page":"301-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4971-7358","authenticated-orcid":false,"given":"Aulbrey","family":"Drisaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Weeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Neyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Orvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Bonilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeke","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Bohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"627_CR1","unstructured":"Valproic Acid [package insert]. Upsher-Smith Laboratories,Inc., Maple Grove, MN. 2016."},{"key":"627_CR2","first-page":"392","volume":"35","author":"MM Goldenberg","year":"2010","unstructured":"Goldenberg MM. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. P&T. 2010;35:392\u2013415.","journal-title":"P&T"},{"key":"627_CR3","unstructured":"Hilal-Dandan R, Brunton LL. Pharmacotherapy of the epilepsies. In: Goodman and Gilman\u2019s manual of pharmacology and therapeutics, 2nd edn. New York: McGraw-Hill Education; 2016."},{"key":"627_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1528-1157.1985.tb05406.x","volume":"26","author":"RH Levy","year":"1985","unstructured":"Levy RH, Schmidt D. Utility of free level monitoring of antiepileptic drugs. Epilepsia. 1985;26:199\u2013205.","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"627_CR5","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1007\/s11739-012-0802-0","volume":"7","author":"A Gatta","year":"2012","unstructured":"Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7(Suppl 3):S193\u20139.","journal-title":"Intern Emerg Med"},{"key":"627_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1254\/jphs.FPE04007X","volume":"97","author":"J Hermida","year":"2005","unstructured":"Hermida J, Tutor JC. A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients. J Pharmacol Sci. 2005;97:489\u201393.","journal-title":"J Pharmacol Sci"},{"key":"627_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2147\/COPD.S85831","volume":"10","author":"CW Chen","year":"2015","unstructured":"Chen CW, Chen YY, Lu CL, et al. Severe hypoalbuminemia is a strong independent risk factor for acute respiratory failure in COPD: a nationwide cohort study. Int J Chronic Obstr Pulm Dis. 2015;10:1147\u201354.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"627_CR8","doi-asserted-by":"publisher","first-page":"e105983","DOI":"10.1371\/journal.pone.0105983","volume":"9","author":"ME Jellinge","year":"2014","unstructured":"Jellinge ME, Henriksen DP, Hallas P, Brabrand M. Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: a prospective, observational, cohort study. PLoS ONE. 2014;9:e105983.","journal-title":"PLoS ONE"},{"key":"627_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2147\/CIA.S52259","volume":"8","author":"T Mizuno","year":"2013","unstructured":"Mizuno T, Mizokami F, Fukami K, et al. The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia. Clin Interv Aging. 2013;8:1323\u20138.","journal-title":"Clin Interv Aging"},{"key":"627_CR10","unstructured":"Valproic Acid, Free and Total [Internet]. Laboratory Test Directory. [cited 2018 Aug 23] \n                    http:\/\/ltd.aruplab.com\/Tests\/Pub\/0099310\n                    \n                  ."},{"key":"627_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1528-1157.1989.tb05478.x","volume":"30","author":"H Gough","year":"1989","unstructured":"Gough H, Goggin T, Crowley M, Callaghan N. Serum bilirubin levels with antiepileptic drugs. Epilepsia. 1989;30:597\u2013602.","journal-title":"Epilepsia"},{"key":"627_CR12","first-page":"196","volume":"1","author":"S Jankovic","year":"2005","unstructured":"Jankovic S. Increase in bilirubin plasma concentration in patients taking sodium valproate. Pharmacology. 2005;1:196\u20137.","journal-title":"Pharmacology"},{"key":"627_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ejpn.2006.09.002","volume":"10","author":"A Attilakos","year":"2006","unstructured":"Attilakos A, Voudris KA, Garoufi A, et al. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study. Eur J Paediatr Neurol. 2006;10:237\u201340.","journal-title":"Eur J Paediatr Neurol"},{"key":"627_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0920-1211(91)90070-V","volume":"8","author":"HA Ring","year":"1991","unstructured":"Ring HA, Heller AJ, Marshall WJ, Johnson AL, Reynolds EH. Plasma uric acid in patients receiving anticonvulsant monotherapy. Epilepsy Res. 1991;8:241\u20134.","journal-title":"Epilepsy Res"},{"key":"627_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/art.1780220707","volume":"22","author":"EW Holmes","year":"1979","unstructured":"Holmes EW, Blondet P. Urate binding to serum albumin: lack of influence on renal clearance of uric acid. Arthritis Rheum. 1979;22:737\u20139.","journal-title":"Arthritis Rheum"},{"key":"627_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.36.4.374","volume":"36","author":"L Ramsay","year":"1977","unstructured":"Ramsay L, Mitchell T, Shelton J. Plasma uric acid and plasma albumin in healthy subjects. Ann Rheum Dis. 1977;36:374\u20137.","journal-title":"Ann Rheum Dis"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-018-0627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-018-0627-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-018-0627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:16:04Z","timestamp":1571166964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-018-0627-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1007\/s12028-018-0627-4","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"assertion":[{"value":"16 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}